Vivian Lewis

Vivian Lewis is editor and founder of Global-Investing.com, the daily blog newsletter for Americans and others seeking to internationalize their portfolios. She brings unique experience and competences to the business of picking foreign stocks. After graduating from Harvard magna cum laude, Vivian lived 18 years in Europe where she worked as a financial journalist. Back in the U.S. in 1989, she decided that retail investors managing their own portfolios deserved the kind of information she had been digging up for mutual fund and pension fund managers, so she started Global Investing. It covers the American Depositary Receipt market, where now some 2,500 shares can be bought, and Canadian stocks. Apart from ADRs, Global Investing also covers yield instruments like yankee bonds and foreign preferred stocks. And for start-up global investors, the newsletter recommends closed-end and exchange-traded funds outside the U.S.

Read More

Fiat Chrysler (FCAU)

This automaker’s September sales soared nearly 14%. Its growth potential, as well as its bid for GM make the company’s stock attractive. Fiat Chrysler (FCAU) from Global Investing My main reason for tipping Big Board stock Fiat Chrysler (FCAU) is that its bid for GM likely...
Read More

Global Investing

Global Investing is a newsletter for investors seeking to build an international portfolio of stocks and bonds from around the world without leaving Wall Street or their regular brokers. It covers American Depositary Receipts and other foreign stocks and bonds trading in the and...
Read More

Benitec Biopharma (BTEBD)

Exciting developments are at hand for this biotech with a new ticker. Benitec Biopharma (BTEBD) from Global Investing Benitec Biopharma (BTEBD) announced hot news. First, the company will issue US$70 million in new ADRs under its new ticker symbol, BTEBD (BLT in Australia), each new US equal...
Read More

Tata Motors (TTM)

Here’s a turnaround Indian stock supported by urban demand. Tata Motors (TTM) from Global Investing Deutsche Bank and Société Générale analysts have upgraded my stock idea, Tata Motors (TTM). Jaguar-Landover provides most of TTM revenues but my focus is on the Tata side, which was straggling when sold...
Read More

Delek Group (DGRLY)

Today’s 2014 Top Picks update is an energy company. It recently reported first quarter revenues of NIS 9 billion and net income, excluding amortization due to assets in the process of being sold, of approximately NIS 111 million (Israeli currency). Delek Group (DGRLY) from Global Group...
Read More

Delek Group (DGRLY)

Today's new Top Pick for 2014 has significant potential in gasfield opportunities in the Middle East. Here’s the recommendation, from Global Investing Editor Vivian Lewis. Delek Group (DGRLY) from Global Investing Delek Group (DGRLY) tried to hide bad news by reporting on Q3 on Thanksgiving Day. quarterly...
Read More

Israel Chemicals (ISCHF)

Today’s pick is getting ready for its NYSE debut, which may give the shares a boost. Meanwhile, investors will enjoy its 8.4%+ dividend. Israel Chemicals (ISCHF) from Vivian Lewis, Global Investing As expected, Israel Chemicals—operator of the Dead Sea Works—was hurt by the phosphate price wars. operating...
Read More

Compugen (CGEN)

Sell Some Compugen (CGEN) from Global Investing, recommended at $2 on July 27, 2009 Not willing to be left poor under the new two-molecule cancer licensing arrangement with Bayer, fellow Israeli Compugen proposes a shareholder vote in September to boost their board’s options compensation. With $10 million up front $30...
Read More

PROLOR Biotech, Inc. (PBTH)

Follow-Up: PROLOR Biotech, Inc. (PBTH) PBTH was recommended by Global Investing at $4.81 in Investment Digest issue 732, dated December 5, 2012. “OPKO Health (OPK) and PROLOR Biotech, Inc. (PBTH $6 Amex) just announced that they have signed a definitive merger agreement under which OPKO will acquire PROLOR, biopharmaceutical...
Read More